All posts by: Michael Zand

About Michael Zand

Stem cells may speed up screening of drugs for rare cancers – Medical Xpress

Continue reading

2016-08-02 NEWS

Stem cells may speed up screening of drugs for rare cancers
Medical Xpress
1 issue of Clinical Cancer Research, describes experiments that transform human stem cells into an aggressive and rare form of pediatric brain cancer called medulloblastoma. Those cancer cells’ genetic profiles can then be rapidly compared with

and more »

Continue reading

2016-08-02 NEWS

Edison Issues Update on International Stem Cell (ISCO)
PR Newswire (press release)
International Stem Cell announced in July 2016 that it had dosed the first patient in the Phase I dose escalation study examining its neural stem cell product ISC-hpNSC for the treatment of moderate to severe Parkinson’s disease. The study will enrol

and more »

Continue reading

2016-08-02 NEWS

PR Web

Stem cell collection benefits patients and practice
DrBicuspid.com
My involvement in dental stem cell technology started 10 years ago, when my oldest daughter was about to lose her fist primary tooth. Since my wife and I missed the opportunity to store our children’s cord blood, I thought stem cells were something I
Global Stem Cells Group Announces Training Course Scheduled in Manila, PhilippinesPress Release Rocket

all 2 news articles »

Continue reading

2016-08-02 NEWS

Hartlepool Mail

Hartlepool dad’s MS stem cell treatment brings hope to others
Hartlepool Mail
Eric, 50, has returned to his home on Jowitt Road after undergoing a Hematopoietic Stem Cell Transplantation (HSCT) at the Riaz Clinic in Mexico, and already the story of his amazing journey to recovery has sparked hope in MS patients. He took a chance …

Continue reading

2016-08-02 NEWS

Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation
Dove Medical Press
Stem cell therapy resulted in an improvement in long-term (12 months) left ventricular ejection fraction of 3.15% (95% confidence interval 1.01–5.29, P<0.01). The 3-month to 4-month, 6-month, and 12-month left ventricular end-systolic volume showed …